Physician profile
George C Ibars
NPI 1356322986
$3,827.52
in general payments reported to CMS, 2019-2025
23 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $112 · 2021: $1,736 · 2022: $390 · 2023: $473 · 2024: $369 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,170.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,654.27 | 2020-2025 | Everest Spinal System, Vitoss, Prolift |
| Abbvie INC. | $833.01 | 2021-2025 | |
| Depuy Synthes Sales INC. | $231.31 | 2021-2022 | |
| Osseus Fusion Systems, LLC | $177.77 | 2019 | |
| Intrinsic Therapeutics | $132.55 | 2021-2022 | |
| Providence Medical Technology, INC. | $103.01 | 2021-2025 | |
| Medtronic, INC. | $89.32 | 2022-2023 | Kyphon Express II Kyphopak Tray |
| Portola Pharmaceuticals, LLC | $84.47 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $63.86 | 2019-2020 | |
| Surgalign Spine Technologies, INC. | $46.49 | 2019-2021 | |
| Cerapedics INC. | $42.93 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Medical Device Business Services, INC. | $41.87 | 2019 | |
| Djo, LLC | $39.84 | 2019-2025 | Cmf |
| Integrity Implants INC. | $39.81 | 2021 | |
| Nuvasive, INC. | $35.79 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $35.29 | 2021 | |
| Orthofix Medical, INC. | $33.65 | 2019-2021 | |
| Radius Health, INC. | $32.89 | 2021 | |
| Aesculap Implant Systems, LLC | $30.00 | 2021 | |
| Mimedx Group, INC. | $26.56 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $20.67 | 2024 | |
| Medtronic USA, INC. | $18.82 | 2019 | |
| Integra Lifesciences Corporation | $13.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Ibars listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.